A critical factor in understanding why non-treatment (i.e., monitoring with either active surveillance or watchful waiting) may be a better idea than immediate treatment for men with localized prostate cancer has to do with risk of death from causes other than the cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: localized, mortality, other, prostate cancer, risk | 9 Comments »
A newly published study appearing in the Journal of the American Board of Family Medicine appears to demonstrate that patients newly diagnosed with localized prostate cancer grossly underestimate their life expectancy without treatment and grossly overestimate the survival benefit of treatment. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: expectation, localized, outcome, patient, prostate cancer, Treatment | 10 Comments »
It has long been unclear what the optimal radiation treatment was for men with pathologic T3-4N0 prostate cancer following radical prostatectomy (RP). Trabulsi et al. have recently conducted a multi-institutional analysis of the relative values of early adjuvant radiation therapy (ART) vs. delayed (salvage) radiation therapy (SRT) in such patients. … READ MORE …
Filed under: Management, Treatment | Tagged: adjuvant, prostate cancer, radiation, salvage, therapy | Leave a comment »
We say that we need clinical trials, but only a small percentage of patients actually enroll in these trials. We’ve known this for a while, but it has just been confirmed.
A study published in the Journal of Clinical Oncology shows that the overall enrollement in cancer trials hovers in the very low single digits. Men were less likely than women to enroll. Enrollment was lower for African-American and older patients. Lack of enrollment badly hampers the relevance (generalizability) of any trial. This is because it brings an extreme volunteer bias, whose impact on observations is hard to gauge.
To understand prostate cancer tomorrow, we need enrollment today.
Filed under: Drugs in development | Tagged: clinical trials, prostate cancer | Leave a comment »
Anyone who has learned a reasonable amount about the diagnosis and management of prostate cancer has learned that the prostate specific antigen or PSA test is not a particularly good test for identifying or monitoring the status of men with active prostate cancer. It is simply better than anything else we have. Researchers have been looking for better options for years. … MORE
Filed under: Diagnosis | Tagged: Diagnosis, PCA3, prostate cancer | Leave a comment »
You can get information on the internet, but Dr. Krongrad suggests you also consider some books.
There are different kinds of prostate cancer books. First we have the encyclopedia, useful because it puts in one place everything you might want to know. And you can take it on the plane and to bed, places you rarely take your internet. As one great example of the prostate cancer encyclopedia I would cite the American Cancer Society’s Complete Guide to Prostate Cancer. In this book, written by medical experts, you can find basic definitions and learn about diagnosis and treatment. This kind of book will help you think of questions to ask. … MORE
Filed under: Living with Prostate Cancer | Tagged: Arnon Krongrad MD, books, dr. krongrad, prostate cancer | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 